10X Genomics Inc Financial Flexibility Index
10X Genomics Inc financial flexibility index. 10X Genomics Inc (TXG) has a Financial Flexibility Index of 0.09x as of June 2026. Free cash flow of $18.56 Million (operating CF $16.97 Million minus capex $1.59 Million) represents 0% of total liabilities ($204.52 Million). See TXG cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of 10X Genomics Inc (2017–2025)
Financial flexibility index of 10X Genomics Inc from 2017 to 2025. Historical Financial Flexibility Index trend for 10X Genomics Inc across 9 annual periods. Check how high is 10X Genomics Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
10X Genomics Inc Financial Flexibility Index by Year (2017–2025)
10X Genomics Inc financial flexibility index by year from 2017 to 2025. Year-by-year free cash flow to debt coverage for 10X Genomics Inc. For the full cash flow conversion analysis, see 10X Genomics Inc cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.58x | $141.99 Million | $136.05 Million | $245.04 Million | ▲ +534.0% |
| 2024 | 0.09x | $19.06 Million | $6.66 Million | $208.50 Million | ▼ -40.3% |
| 2023 | 0.15x | $34.33 Million | $-15.20 Million | $224.10 Million | ▼ -65.1% |
| 2022 | 0.44x | $98.06 Million | $-33.61 Million | $223.24 Million | ▲ +10.6% |
| 2021 | 0.40x | $79.91 Million | $-21.37 Million | $201.26 Million | ▲ +142.1% |
| 2020 | -0.94x | $-179.50 Million | $-217.90 Million | $190.27 Million | ▼ -326.5% |
| 2019 | 0.42x | $77.39 Million | $34.63 Million | $185.84 Million | ▲ +305.7% |
| 2018 | -0.20x | $-69.70 Million | $-76.41 Million | $344.30 Million | ▼ -448.5% |
| 2017 | -0.04x | $-6.94 Million | $-10.70 Million | $188.12 Million | — |